Article info
Editorials
The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension
- Correspondence to Dr John D Bisognano, Professor of Medicine/Cardiology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 601-7, Rochester, NY 14642, USA; john_bisognano{at}urmc.rochester.edu
Citation
The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension
Publication history
- First published August 15, 2012.
Online issue publication
March 15, 2016
Article Versions
- Previous version (15 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions